Skip to main content
. 2022 Aug 28;23(17):9754. doi: 10.3390/ijms23179754

Table 2.

Gene comparison efficiency statistics.

Samples Mapped Reads Unique Mapped Reads Multiple Map Reads
Control-1 67,898,715 (95.98%) 66,065,506 (93.39%) 1,833,209 (2.59%)
Control-2 62,849,152 (96.34%) 61,097,600 (93.66%) 1,751,552 (2.69%)
Control-3 60,714,671 (96.27%) 59,081,017 (93.68%) 1,633,654 (2.59%)
E. coli-1 46,168,875 (95.96%) 44,891,836 (93.31%) 1,277,039 (2.65%)
E. coli-2 49,843,598 (96.11%) 48,508,765 (93.54%) 1,334,833 (2.57%)
E. coli-3 43,776,016 (96.19%) 42,624,022 (93.66%) 1,151,994 (2.53%)
pBD2-1 39,790,781 (96.01%) 38,760,294 (93.53%) 1,030,487 (2.49%)
pBD2-2 46,057,704 (96.38%) 44,834,945 (93.82%) 1,222,759 (2.56%)
pBD2-3 40,692,378 (95.84%) 39,483,201 (92.99%) 1,209,177 (2.85%)

Notes: Control, E. coli and pBD2 indicate the IPEC-J2 in the control, E. coli and E. coli +pBD2 groups, and 1–3 indicate the three replicates, respectively.